Public research preview

Richard W. Allen, Representative disclosure: AbbVie Inc. Common Stock (ABBV)

Disclosed a buy transaction in AbbVie Inc. Common Stock (ABBV). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
0/100
Signal Quality
63/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
10 Aug 2023, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
1185 days

Timeline

Transaction date

12 May 2020

Public disclosure

10 Aug 2023

Now

Tracked today

Filing delay: 1185 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

Most of the move happened before this disclosure became public: the stock peaked +110.1% above the transaction-date close and has since retraced -8.3% from that peak. Buying now is a pullback entry on the disclosed position, not a fresh breakout.

Stock path

ABBV from pre-transaction context through latest close.

Bought

12 May 2020 · 71.381 USD · Not public yet

System decision

Would have bought · Discount entryThe strategy would have bought this signal, but the entry window has closed. Simulated entry on 10 Aug 2023 at 137.508 USD. Since entry: +62.2%. Planned exit on 8 Sept 2023 after 20 trading days.

Not public yetWindow closed65.2151.9238.7USDDate12 May10 Aug8 JunOfficial disclosure10 AugPlanned exit137.5System buyBoughtDisclosureLatest
  • Not public yet
  • Buy window
  • Window closed
  • System buy
  • Planned exit
Observed transaction close
71.381
Observed disclosure close
137.508
Observed latest close
223.07
Pre-disclosure move
+92.6%
Post-disclosure move
+62.2%
Market-adjusted move
+62.2%
1w since disclosure
-0.9%
1m since disclosure
-1.6%
3m since disclosure
-5.3%
Pre-disclosure peak run-up
+110.1%
Retrace from peak
-8.3%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $15,001 - $50,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 10 Aug 2023, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value15001
sourcehouse_stock_act
tickerABBV
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023082.pdf
personNameRichard W. Allen
amountRange$15,001 - $50,000
companyNameAbbVie Inc. (ABBV)
publishedAt2023-08-10T00:00:00.000Z
rawDocumentIdraw-us-house-20023082-7
disclosureDate2023-08-10
transactionDate2020-05-12
transactionTypeP